Etravirine/Rilpivirine-Specific Mutations Selected by EFV and NVP in Kenyan Patients Failing ART
…Kenyan patients with non-B subtypes failing first line therapy with neviripine or efavirenz. Methodology: RV288 is a multi-center PEPFAR Basic Program Evaluation that is being conducted in Kenya, Tanzania, Uganda…